WINT (OTC)
WINDTREE THERAPEUTICS NEW
$0.018000
+0.002000 (+12.50%)
Prev close: $0.016000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig E. Fraser
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.25M
- Employees
- 32
- P/E (TTM)
- —
- P/B (TTM)
- 1.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-277.00 | $-115.77 | -161.2300 | -139.27% |
|
Jun 2024 (Q2)
|
$-1,045.55 | $-413.61 | -631.9400 | -152.79% |
|
Dec 2023 (Q4)
|
$-37.00 | $-47.94 | +10.9400 | +22.82% |
|
Sep 2023 (Q3)
|
$-43.00 | $-32.13 | -10.8700 | -33.83% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$10.01M |
| Operating Expenses | $33.50M |
| Research and Development | $8.54M |
| Other Operating Expenses | $16.21M |
| Operating Income/Loss | -$33.50M |
| Income/Loss From Continuing Operations After Tax | -$39.99M |
| Income/Loss From Continuing Operations Before Tax | -$43.50M |
| Income Tax Expense/Benefit | -$3.51M |
| Income Tax Expense/Benefit, Deferred | -$3.44M |
| Net Income/Loss | -$39.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$48.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $3.55M |
| Preferred Stock Dividends And Other Adjustments | $3.55M |
| Basic Earnings Per Share | $318.77 |
| Basic Average Shares | 1,172,686,954 |
| Assets | $15.98M |
| Current Assets | $7.21M |
| Noncurrent Assets | $8.78M |
| Fixed Assets | $61.00K |
| Other Non-current Assets | $8.72M |
| Liabilities | $27.58M |
| Current Liabilities | $21.90M |
| Accounts Payable | $1.65M |
| Other Current Liabilities | $20.25M |
| Noncurrent Liabilities | $5.68M |
| Equity | -$11.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$11.61M |
| Temporary Equity | $9.00K |
| Temporary Equity Attributable To Parent | $9.00K |
| Liabilities And Equity | $15.98M |
| Net Cash Flow From Operating Activities | -$15.12M |
| Net Cash Flow From Operating Activities, Continuing | -$15.12M |
| Net Cash Flow From Investing Activities | -$5.97M |
| Net Cash Flow From Investing Activities, Continuing | -$5.97M |
| Net Cash Flow From Financing Activities | $19.00M |
| Net Cash Flow From Financing Activities, Continuing | $19.00M |
| Net Cash Flow | -$2.10M |
| Net Cash Flow, Continuing | -$2.10M |
| Comprehensive Income/Loss | -$39.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.99M |
| Other Comprehensive Income/Loss | $0.00 |